Found 0 matching trials
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
PHASE1This is a study of the efficacy and safety of BXCL501 in children and adole...
Location
BioXcel Clinical Research Site
Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal
PHASE1This Phase 1b/2 inpatient study assessed the safety, pharmacokinetics, and ...
Location
BioXcel Clinical Research Site
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
PHASE4This is a single-arm pilot study to examine the impact of BXCL501 (sublingu...
Location
Multiple Locations
BXCL501 After Stress to Increase Recovery Success
PHASE2This study will examine the safety and efficacy of BXCL501 to reduce ASR sy...
Location
University of Florida College of Medicine - Jacksonville
Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study
PHASE1The overall objective of the proposed study is to determine if Dexmedetomid...
Location
VA Connecticut Healthcare System
Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia
PHASE1This is a two-stage adaptive Phase Ib trial design, that will identify two ...
Location
BioXcel Clinical Research Site
An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia
PHASE2A randomized, double-blind, placebo-controlled parallel group 3-arm study a...
Location
Bioxcel Clinical Research Site